XML 152 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Changes in (Deficit) Equity - USD ($)
Preferred Stock
Series A
Preferred Stock
Series B
Preferred Stock
Series C
Preferred Stock
Series D
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Statutory Reserve
Accumulated Other Comprehensive Loss (Deficit)
Noncontrolling Interest
Total
Balance at Dec. 31, 2022 $ 9,000,000   $ 67 $ 65,950,661 $ (522,500) $ (63,062,721) $ 6,578 $ (213,137) $ 11,158,948
Balance (in Shares) at Dec. 31, 2022 9,000   667,572              
Balance (in Shares) at Dec. 31, 2022             (3,467)          
Shares issued for adjustments    
Shares issued for adjustments (in Shares)         3,333              
Issuance of Series B Convertible Preferred Stock for equity method investment $ 11,000,000     11,000,000
Issuance of Series B Convertible Preferred Stock for equity method investment (in Shares)   11,000                    
Issuance of common stock as convertible note payable commitment fee   $ 1 236,399   236,400
Issuance of common stock as convertible note payable commitment fee (in Shares)         11,333              
Sale of common stock, net   $ 3 414,393   414,396
Sale of common stock, net (in Shares)         30,442              
Issuance of common stock for services   $ 3 999,652   999,655
Issuance of common stock for services (in Shares)         24,089              
Stock-based compensation   284,977   284,977
Foreign currency translation adjustment     (18,590) (18,590)
Net loss for the year     (16,707,010) (16,707,010)
Balance at Dec. 31, 2023 $ 9,000,000 $ 11,000,000   $ 74 67,886,082 $ (522,500) (79,769,731) 6,578 (231,727) $ 7,368,776
Balance (in Shares) at Dec. 31, 2023 9,000 11,000   736,769              
Balance (in Shares) at Dec. 31, 2023             (3,467)         3,467
Issuance of common stock as convertible note payable commitment fee     $ 1 41,999   $ 42,000
Issuance of common stock as convertible note payable commitment fee (in Shares)         7,000              
Stock-based compensation     13,533   13,533
Foreign currency translation adjustment       (2,920) (2,920)
Net loss for the year       (1,367,513) (1,367,513)
Balance at Mar. 31, 2024 $ 9,000,000 $ 11,000,000     $ 75 67,941,614 $ (522,500) (81,137,244) 6,578 (234,647) 6,053,876
Balance (in Shares) at Mar. 31, 2024 9,000 11,000     743,769              
Balance (in Shares) at Mar. 31, 2024             (3,467)          
Balance at Dec. 31, 2023 $ 9,000,000 $ 11,000,000   $ 74 67,886,082 $ (522,500) (79,769,731) 6,578 (231,727) $ 7,368,776
Balance (in Shares) at Dec. 31, 2023 9,000 11,000   736,769              
Balance (in Shares) at Dec. 31, 2023             (3,467)         3,467
Shares issued for adjustments   $ 21 (21)  
Shares issued for adjustments (in Shares)         206,033              
Issuance of common stock as convertible note payable commitment fee   $ 3 320,543   320,546
Issuance of common stock as convertible note payable commitment fee (in Shares)         33,800              
Sale of common stock, net   $ 28 2,544,283   2,544,311
Sale of common stock, net (in Shares)         281,843              
Issuance of common stock upon cashless exercise of stock warrants   $ 4 (4)  
Issuance of common stock upon cashless exercise of stock warrants (in Shares)         42,381              
Issuance of common stock for services   $ 15 530,335   530,350
Issuance of common stock for services (in Shares)         145,153              
Reclassification of derivative liability to equity   2,354   2,354
Sale of Series C Convertible Preferred Stock $ 3,500,000     3,500,000
Sale of Series C Convertible Preferred Stock (in Shares)     3,500                  
Issuance of pre-funded warrants   688,794   688,794
Stock-based compensation   51,159   51,159
Foreign currency translation adjustment     (273) (273)
Net loss for the year     (7,903,394) (7,903,394)
Balance at Dec. 31, 2024 $ 9,000,000 $ 11,000,000 $ 3,500,000   $ 145 72,023,525 $ (522,500) (87,673,125) 6,578 (232,000) $ 7,102,623
Balance (in Shares) at Dec. 31, 2024 9,000 11,000 3,500   1,445,979              
Balance (in Shares) at Dec. 31, 2024             (3,467)         3,467
Issuance of common stock upon cashless exercise of stock warrants   $ 19 (19)            
Issuance of common stock upon cashless exercise of stock warrants (in Shares)         186,877              
Issuance of common stock for services   $ 2 111,230         111,232  
Issuance of common stock for services (in Shares)         22,278              
Reclassification of derivative liability to equity     18,853         18,853  
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock $ (9,000,000) $ 8,837,527 162,473  
Series D Convertible Preferred Stock issued in exchange of Series A Convertible Preferred Stock (in Shares) (9,000) 5,000              
Series B Convertible Preferred Stock extinguished related to sale of equity method investment   $ (11,000,000)       2,348,695           (8,651,305)
Series B Convertible Preferred Stock extinguished related to sale of equity method investment (in Shares)   (11,000)                    
Stock-based compensation 9,159   9,159
Foreign currency translation adjustment   279 279
Net loss for the year   (2,482,111)   (2,482,111)
Balance at Mar. 31, 2025 $ 3,500,000 $ 8,837,527 $ 166 $ 74,673,916 $ (522,500) $ (90,155,236) $ 6,578 $ (231,721) $ (3,891,270)
Balance (in Shares) at Mar. 31, 2025 3,500 5,000 1,655,134              
Balance (in Shares) at Mar. 31, 2025             (3,467)         3,467